Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NC Medial Research Inc
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males and females, age 18 to 85 years inclusive
Clinical evidence of acute ischemic unilateral cerebral infarction
\- Evidence of neurologic deficits as defined by NIHSS 6 to 18 or NIHSS \< 6 with Fugl-Meyer upper extremity subtotal 6 to 40 inclusive
Women of child bearing potential who agrees to take acceptable birth control as described in the ICF
Provide written informed consent before participation, either by patient or a legal representative
You may not be if
Progressive neurologic deficit
An inability to undergo an MRI scan
Any malignancies within the last 5 years
Previous organ transplantation
Participation in another clinical trial with an investigational drug, device or biologic within the preceding 3 months
Women of childbearing potential with a positive pregnancy test
Already dependent in activities of daily living (Rankin scale 3 or more) before the present acute stroke
Known hypersensitivity, allergy or intolerance to the similar biologic interventions
Any other clinically relevant acute or chronic diseases which could interfere with patients' safety during the trial, or expose them to undue risk, or which could interfere with study objectives judged by Investigator based on medical history, physical examination, laboratory tests and/or ECG
Clareo Health | A Study of NCS-01 in Patients With Acute Ischemic Stroke
